SIGN UP
LOG IN
MARKET
ENDPQ
ENDPQ
Endo Intl Plc
EXMKT
0.0025
+0.0012
+92.31%
Closed 10:03 12/07 EST
OPEN
0.0025
PREV CLOSE
0.0013
HIGH
0.0025
LOW
0.0025
VOLUME
1.00K
TURNOVER
3
52 WEEK HIGH
7.07
52 WEEK LOW
0.0002
MARKET CAP
588.05K
P/E (TTM)
-0.0023
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ENDPQ last week (1127-1201)?
Weekly Report · 4d ago
Weekly Report: what happened at ENDPQ last week (1120-1124)?
Weekly Report · 11/27 09:40
Generic Drugmaker Endo's Bankruptcy: Lenders Suggest $465M Payment To Settle Dispute With Federal Entities: Report
Endo international's lenders have proposed a deal to settle with u.s. Government agencies in disagreement with the pharmaceutical company's restructuring strategy. Endo's first-lien debtholders propose to provide $365 million to the objecting agencies over a decade. The proposal suggests allocating up to $465 million to these agencies.
Benzinga · 11/22 11:56
Endo Creditors Offer U.S. Government $465 Million to Push Sale Forward
Endo's first-lien debtholders say the government agencies would receive $365 million over 10 years. The justice department objected to endo's restructuring plan to hand control to creditors. Endo filed for bankruptcy in august 2022 to address mass opioid lawsuits.
The Wall Street Journal · 11/22 03:32
Weekly Report: what happened at ENDPQ last week (1113-1117)?
Weekly Report · 11/20 09:40
Weekly Report: what happened at ENDPQ last week (1106-1110)?
Weekly Report · 11/13 09:37
Endo International Non-GAAP EPS of $0.56, revenue of $451.67M
Endo international reports q3 non-gaap eps of $0.56, revenue of $451.67m (-16.6% y/y) expected full-year 2023 adjusted financial results reflect lower-than-expected demand for xiaflex and supprelin.
Seeking Alpha · 11/06 22:40
Weekly Report: what happened at ENDPQ last week (1030-1103)?
Weekly Report · 11/06 09:38
About ENDPQ
Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The Company's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.
Webull offers Endo International PLC stock information, including EXMKT: ENDPQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENDPQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ENDPQ stock methods without spending real money on the virtual paper trading platform.